Literature DB >> 12365877

Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.

Ellen Frank1, Jill M Cyranowski, Paola Rucci, M Katherine Shear, Andrea Fagiolini, Michael E Thase, Giovanni B Cassano, Victoria J Grochocinski, Bryan Kostelnik, David J Kupfer.   

Abstract

BACKGROUND: Given the observed association between panic disorder and bipolar disorder and the potential negative influence of panic symptoms on the course of bipolar illness, we were interested in the effects of what we have defined as "panic spectrum" conditions on the clinical course and treatment outcome in patients with bipolar I (BPI) disorder. We hypothesized that lifetime panic spectrum features would be associated with higher levels of suicidal ideation and a poorer response to acute treatment of the index mood episode in this patient population.
METHODS: A sample of 66 patients with BPI disorder completed a self-report measure of lifetime panic-agoraphobic spectrum symptoms. Patients falling above and below a predefined clinical threshold for panic spectrum were compared for clinical characteristics, the presence of suicidal ideation during acute treatment, and acute treatment response.
RESULTS: Half of this outpatient sample reported panic spectrum features above the predefined threshold. These lifetime features were associated with more prior depressive episodes, higher levels of depressive symptoms, and greater suicidal ideation during the acute-treatment phase. Patients with BPI disorder who reported high lifetime panic-agoraphobic spectrum symptom scores took 27 weeks longer than those who reported low scores to remit with acute treatment (44 vs 17 weeks, respectively).
CONCLUSIONS: The presence of lifetime panic spectrum symptoms in this sample of patients with BPI disorder was associated with greater levels of depression, more suicidal ideation, and a marked (6-month) delay in time to remission with acute treatment. Alternate treatment strategies are needed for patients with BPI disorder who endorse lifetime panic spectrum features.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365877     DOI: 10.1001/archpsyc.59.10.905

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  34 in total

1.  Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.

Authors:  Regina Sala; Benjamin I Goldstein; Carmen Morcillo; Shang-Min Liu; Mariela Castellanos; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2012-04-24       Impact factor: 4.791

2.  The influence of comorbid disorders on the episodicity of bipolar disorder in youth.

Authors:  S Yen; R Stout; H Hower; M A Killam; L M Weinstock; D R Topor; D P Dickstein; J I Hunt; M K Gill; T R Goldstein; B I Goldstein; N D Ryan; M Strober; R Sala; D A Axelson; B Birmaher; M B Keller
Journal:  Acta Psychiatr Scand       Date:  2015-10-17       Impact factor: 6.392

3.  A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.

Authors:  Keming Gao; Stephen J Ganocy; Carla Conroy; Brittany Brownrigg; Mary Beth Serrano; Joseph R Calabrese
Journal:  Psychopharmacology (Berl)       Date:  2017-05-24       Impact factor: 4.530

4.  Anxiety disorders and rapid cycling: data from a cohort of 8129 youths with bipolar disorder.

Authors:  Ruby Castilla-Puentes; Regina Sala; Bernardo Ng; Juan Galvez; Alvaro Camacho
Journal:  J Nerv Ment Dis       Date:  2013-12       Impact factor: 2.254

Review 5.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

6.  Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.

Authors:  R Bruce Lydiard; Larry Culpepper; Helena Schiöler; Urban Gustafsson; Björn Paulsson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 7.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

8.  Eating disorders and illness burden in patients with bipolar spectrum disorders.

Authors:  Jennifer E Wildes; Marsha D Marcus; Andrea Fagiolini
Journal:  Compr Psychiatry       Date:  2007-08-20       Impact factor: 3.735

9.  Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.

Authors:  Keming Gao; Marcia L Verduin; David E Kemp; Bryan K Tolliver; Stephen J Ganocy; Omar Elhaj; Sarah Bilali; Kathleen T Brady; Robert L Findling; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

10.  The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.

Authors:  Cristina Toni; Giulio Perugi; Franco Frare; Giuseppe Tusini; Konstantinos N Fountoulakis; Kareen K Akiskal; Hagop S Akiskal
Journal:  Ann Gen Psychiatry       Date:  2008-11-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.